Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: Changes associated with pioglitazone

Diabetes Care

Volumn 34, Issue 3, 2011, Pages 730-733

  Sacks, Harold S ^a,b   Fain, John N ^a   Cheema, Paramjeet ^a   Bahouth, Suleiman W ^a   Garrett, Edward ^b   Wolf, Rodney Y ^b   Wolford, David ^b   Samaha, Joseph ^b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b BAPTIST MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PIOGLITAZONE;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SURGERY; DISEASE ASSOCIATION; DRUG EFFICACY; EPICARDIAL ADIPOSE TISSUE; EPICARDIUM; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; HUMAN TISSUE; IL 10 GENE; IL 1BETA GENE; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION; TREND STUDY;

CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-1BETA; METABOLIC SYNDROME X; PERICARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLIDINEDIONES;

EID: 79956127761     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2083     Document Type: Article

References (15)

1. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003;108:2460-2466 (Pubitemid 37444406)
2. Eiras S, Teijeira-Fernández E, Salgado-Somoza A, et al. Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression. Cytokine 2010;51:207-212
3. Lacobellis G, Pistilli D, Gucciardo M, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005;29:251-255 (Pubitemid 40320925)
4. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J 2007;153:907-917 (Pubitemid 46809849)
5. Vela D, Buja M, Madjid M, et al. The role of peri-adventitial fat in atherosclerosis: an adipose subset with potential diagnostic and therapeutic implications. Arch Pathol Lab Med 2006;130:108-115
6. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-246
7. Goldbach-Mansky R. Blocking interleukin-1 in rheumatic diseases: its initial disappointments and recent successes in the treatment of autoinflammatory diseases: cytokine therapies. Ann N Y Acad Sci 2009;1182:111-123
8. Juge-Aubry CE, Somm E, Giusti V, et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003;52:1104-1110 (Pubitemid 36523343)
9. Nicklin MJH, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000;191:303-311 (Pubitemid 30060919)
10. Francis SE, Camp NJ, Dewberry RM, et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999;99:861-866 (Pubitemid 29094297)
11. Sacks HS, Fain JN, Holman B, et al. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab 2009;94:3611-3615
12. Fain JN, Sacks HS, Bahouth SW, Tichansky DS, Madan AM, Cheema PS. Human epicardial adipokine mRNAs: comparisons with their expression in substernal, subcutaneous and omental fat. Metabolism 2010;59:1379-1386
13. Bonora E, Formentini G, Calcaterra F, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications study. Diabetes Care 2002;25:1135-1141
14. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606 (Pubitemid 13187192)
15. Sewter CP, Blows F, Vidal-Puig A, O'Rahilly S. Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists. Diabetes 2002;51:718-723 (Pubitemid 34760181)